Skip to content

A look at the fight against chronic fatigue syndrome

Chronic fatigue syndrome, also called myalgic encephalomyelitis or ME/CFS, is a debilitating disease that affects more than 1 million Americans. The cause of CFS, which is characterized by at least six months of incapacitating fatigue, remains a mystery, but as a recent segment on ABC 7 News reports, Stanford researchers are making some headway.

Infectious-disease expert Jose Montoya, MD, sees patients at Stanford's ME/CFS clinic, and he believes that research and treatment for the disease is at a turning point. This should be encouraging news to patients, many of whom feel that their suffering isn't validated. "They have seen 10, 15 specialists and many of [the doctors], if not all of them, do not believe them," Montoya says in the interview above.

Previously: Deciphering the puzzle of chronic fatigue syndrome, ME/CFS/SEID: It goes by many aliases, but its blood-chemistry signature is a giveaway and Some headway on chronic fatigue syndrome: Brain abnormalities pinpointed

Popular posts

Biomedical research
Stanford immunologist pushes field to shift its research focus from mice to humans

Much of what we know about the immune system comes from experiments conducted on mice.  But lab mice are not little human beings. The two species are separated by both physiology and  lifestyles. Stanford immunologist Mark Davis is calling on his colleagues to shift their research focus to people.